Neuronetics reported a quarterly loss of $0.16 per share, slightly better than the Zacks Consensus Estimate of a $0.17 loss and improved from a $0.21 loss a year ago. The earnings beat was modest, but the narrower year-over-year loss suggests incremental improvement in fundamentals. The news is likely to have limited near-term market impact.
Neuronetics reported a quarterly loss of $0.16 per share, slightly better than the Zacks Consensus Estimate of a $0.17 loss and improved from a $0.21 loss a year ago. The earnings beat was modest, but the narrower year-over-year loss suggests incremental improvement in fundamentals. The news is likely to have limited near-term market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
